MYnd Analytics, Inc. (56)

Browse by Contract Category

Contracts

Promissory Note date March 31,2022 issued by registrant to Wei Peu Zen (Filed With SEC on May 13, 2022)
License Agreement with Kainos Medicine, Inc. and Emmaus Life Sciences, Inc (Filed With SEC on March 31, 2022)
Transfer Restriction and Voting Agreement dated as of February 8, 2021 between Emmaus Life Sciences, Inc. and the Purchasers thereunder (Filed With SEC on February 16, 2021)
Agreement dated December 23, 2019 between Telcon RF Pharmaceutical Inc. and Emmaus Life Sciences, Inc (Filed With SEC on January 25, 2021)
Third Amendment to Office Lease Agreement dated September 10, 2019 between EMI Holding, Inc. (formerly, Emmaus Life Sciences, Inc.) and RREF Pacific Center LLC (Filed With SEC on January 25, 2021)
Amended and Restated Separation and Distribution Agreement dated as of March 27, 2019, by and among MYnd Analytics, Inc., a Delaware corporation and its wholly-owned subsidiary,... (Filed With SEC on May 13, 2019)
Amendment No. 1 dated May 10, 2019 to the Agreement and Plan of Merger and Reorganization dated as of January 4, 2019 by and among MYnd Analytics, Inc., Athena Merger Subsidiary,... (Filed With SEC on May 13, 2019)
Form of Promissory issued by the registrant to the persons indicated in Schedule A attached to the Form of Promissory Note (Filed With SEC on May 13, 2022)
Promissory Note date January18,2022 issued by registrant to Soomi Niihara (Filed With SEC on May 13, 2022)
Promissory Note dated December 7, 2021 issued by registrant to Soomi Niihara (Filed With SEC on March 31, 2022)
Amendment No. 1 to Loan Agreement dated January 5, 2022 between Emmaus Life Sciences, Inc. and EJ Holdings, Inc (Filed With SEC on March 31, 2022)
Specimen Common Stock Certificate (Filed With SEC on March 31, 2022)
Promissory Note dated May 26, 2021 issued by registrant to Shigeru Matsuda (Filed With SEC on September 1, 2021)
Promissory Note dated April 24, 2021 issued by registrant to Eastwind, Ltd (Filed With SEC on September 1, 2021)
Promissory Note dated February 17, 2021 issued by registrant to Shigeru Matsuda (Filed With SEC on September 1, 2021)
Promissory Note dated January 20, 2021 issued by registrant to Soomi Niihara (Filed With SEC on September 1, 2021)
Form of Promissory note issued by the registrant to the persons indicated in Schedule A attached to the Form of Promissory Note (Filed With SEC on August 26, 2021)
Form of July 31, 2020 Common Stock Purchase Warrants (Filed With SEC on May 4, 2021)
Contingent Common Stock Purchase Warrant (Filed With SEC on May 4, 2021)
Amendment No. 3 to Convertible Promissory Note as of June 15, 2020 of EMI Holding, Inc. (formerly, Emmaus Life Sciences, Inc.) (Filed With SEC on May 4, 2021)
Form of October 8, 2020 Common Stock Purchase Warrants (Filed With SEC on May 4, 2021)
Amendment No. 2 to Convertible Promissory Note of EMI Holding, Inc. (formerly, Emmaus Life Sciences, Inc.) dated as of January 15, 2020 (Filed With SEC on May 4, 2021)
Guaranty dated February 1, 2021 by Emmaus Life Sciences, Inc. in favor of the holders of Amended and Restated 10% Senior Secured Convertible Debentures of EMI Holding, Inc (Filed With SEC on February 22, 2021)
Guaranty dated December 9, 2020 by Emmaus Life Sciences, Inc. in favor or Prestige Capital, Inc (Filed With SEC on February 22, 2021)
Purchase and Sale Agreement between Emmaus Medical, Inc. and Prestige Capital Finance, LLC (Filed With SEC on February 22, 2021)
Form of Convertible Promissory Note of Emmaus Life Sciences, Inc. (included as Exhibit A to Exhibit 10.1) (Filed With SEC on February 16, 2021)
Credit Access and Loan Agreement dated as of January 10, 2020 by and between Emmaus Life Sciences, Inc. and Yutaka Niihara, M.D., M.P.H (Filed With SEC on January 25, 2021)
Right to Sell (Call Option) Agreement between Emmaus Life Sciences, Inc. and Telcon RF Pharmaceutical, Inc (Filed With SEC on January 25, 2021)
Convertible Bond Purchase Agreement between Emmaus Life Sciences, Inc. and Telcon RF Pharmaceutical, Inc (Filed With SEC on January 25, 2021)
Letter of Commitment dated December 23, 2019 between EMI Holding, Inc. (formerly, Emmaus Life Sciences, Inc) and Telcon RF Pharmaceutical, Inc (Filed With SEC on January 25, 2021)
Additional Agreement made as of July 2, 2018 between Telcon Inc. (now known as Telcon RF Pharmaceutical Inc.) and Emmaus Life Sciences, Inc. (now known as EMI Holding, Inc.) and... (Filed With SEC on January 25, 2021)
Raw Material Supply Agreement dated July 12, 2017 between Telcon Inc. (now known as Telcon RF Pharmaceutical Inc.) and Emmaus Life Sciences, Inc. (now known as EMI Holding, Inc.) (Filed With SEC on January 25, 2021)
Amendment for Distributor Agreement entered into as of January 11, 2018 between Telcon Inc. (now known as Telcon RF Pharmaceutical Inc.) and Emmaus Life Sciences, Inc. (now known... (Filed With SEC on January 25, 2021)
Distributor agreement entered into as of June 15, 2017 between Telcon Inc. (now known as Telcon RF Pharmaceutical Inc.) and Emmaus Life Sciences, Inc. (now known as EMI Holding,... (Filed With SEC on January 25, 2021)
Promissory Note dated May 26, 2019 (Filed With SEC on January 25, 2021)
Promissory Note dated April 24, 2019 (Filed With SEC on January 25, 2021)
Specimen Common Stock Certificate (Filed With SEC on January 25, 2021)
API Supply Agreement made as of June 16, 2017 between Telcon Inc. (now known as Telcon RF Pharmaceutical Inc.) and Emmaus Life Sciences, Inc. (now known as EMI Holding, Inc.) (Filed With SEC on January 25, 2021)
Loan Agreement dated October 28, 2020 between Emmaus Life Sciences, Inc. and EJ Holdings, Inc (Filed With SEC on November 13, 2020)
Form of Allonge Amendment No. 1 to Second Amended and Restated 10% Senior Secured Convertible Debenture Due April 21, 2021 (included as Exhibit A to Exhibit 10.1) (Filed With SEC on September 24, 2020)
Registration Rights Agreement dated as of February 28, 2020 between Emmaus Life Sciences, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 3, 2020)
Purchase Agreement dated as of February 28, 2020 between Emmaus Life Sciences, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 3, 2020)
Form of Second Amended and Restated 10% Senior Secured Convertible Debenture Due April 21, 2021 (included as Exhibit A to Exhibit 10.1) (Filed With SEC on February 27, 2020)
Loan Agreement dated as October 3, 2018 between EMI Holding, In. (formerly, Emmaus Life Sciences, Inc.) and EJ Holdings, Inc (Filed With SEC on November 13, 2019)
Form of Exchange Agreement (Filed With SEC on June 28, 2019)
Amendment, dated June 28, 2019, to Warrant Agreements, dated July 19, 2017 and July 25, 2017, between the Company and American Stock Transfer & Trust Company, LLC (Filed With SEC on June 28, 2019)
Amendment to Chairman Services Agreement dated May 30, 2019 (Filed With SEC on June 10, 2019)
Securities Purchase Agreement, dated May 22, 2019, between the Company and the purchasers party thereto (Filed With SEC on May 23, 2019)
Fee Agreement, dated May 22, 2019, between the Company and the Placement Agent (Filed With SEC on May 23, 2019)
Commercial Lease Agreement dated March 13, 2019 (Filed With SEC on May 13, 2019)
Form of Emmaus Lock-Up Agreement dated as of January 4, 2019 (Filed With SEC on January 7, 2019)
Form of MYnd Voting Agreement dated as of January 4, 2019 (Filed With SEC on January 7, 2019)
Form of Emmaus Voting Agreement dated as of January 4, 2019 (Filed With SEC on January 7, 2019)
Form of MYnd Lock-Up Agreement dated as of January 4, 2019 (Filed With SEC on January 7, 2019)
Agreement and Plan of Merger and Reorganization dated as of January 4, 2019, by and among MYnd Analytics, Inc., Athena Merger Subsidiary, Inc. and Emmaus Life Sciences, Inc (Filed With SEC on January 7, 2019)
Separation Agreement dated as of January 4, 2019, by and among MYnd Analytics, Inc., a Delaware corporation and its wholly-owned subsidiary, MYnd Analytics, Inc., a California... (Filed With SEC on January 7, 2019)